BridgeMD
Compares treatment options for Pneumothorax
Official title 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy
ClinicalTrials.gov ID: NCT06958848
What this study is testing
- What it's testing
- The aim of the study is to evaluate postoperative pain in patients receiving a small-bore (16F) chest drain compared to those receiving the standard large-bore (24F) chest drain after minimally invasive pulmonary lobectomy and/or segmentectomy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Informed Consent signed by the patient (all sex and gender)
- Patients' age from ≥ 18 to no age limit at time of study inclusion
- American Society of Anaesthesiologists (ASA) physical status classification I to IV
- Patients with resectable non-small cell lung cancer (NSCLC) deemed operable by minimally invasive surgical technique.
- Minimally invasive anatomical lung resections under general anaesthesia: lobectomy, lobectomy with wedge resection, lobectomy combined with...
You likely can't join if
- Previous thoracic surgery on the same side within 3 months
- Lung cancer complicated with pleural empyema
- Patients with chronic pain who receive opioids/gabapentin/pregabalin
- Patients who consume opiates/benzodiazepines
- Congestive heart failure NYHA Class III or IV
- Liver cirrhosis Child-Pugh Class B and C
See the full eligibility criteria
- Informed Consent signed by the patient (all sex and gender)
- Patients' age from ≥ 18 to no age limit at time of study inclusion
- American Society of Anaesthesiologists (ASA) physical status classification I to IV
- Patients with resectable non-small cell lung cancer (NSCLC) deemed operable by minimally invasive surgical technique.
- Minimally invasive anatomical lung resections under general anaesthesia: lobectomy, lobectomy with wedge resection, lobectomy combined with segmentectomy, segmentectomy with wedge resection, bilobectomy
- Previous thoracic surgery on the same side within 3 months
- Lung cancer complicated with pleural empyema
- Patients with chronic pain who receive opioids/gabapentin/pregabalin
- Patients who consume opiates/benzodiazepines
- Congestive heart failure NYHA Class III or IV
- Liver cirrhosis Child-Pugh Class B and C
- Renal insufficiency requiring dialysis and/or estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m2
- Patients with coagulopathy or bleeding disorders: von Willebrand disease, Hemophilia; Thrombocytopenia (\<50 G/l), requiring platelet transfusion
- Patients with neuralgia
- Chest pain (site of surgery) without taking painkillers, measured by VAS while coughing \> 10 mm
- Not consolidated rib fractures (in the last 3 months) on the side of surgical procedure
- Open anatomical lung resection, including pneumonectomy
- Insertion of 2 or more chest tubes
- Need for patient controlled intravenous anaesthesia or patient controlled epidural anaesthesia
- Patients intubated/sedated (not suitable due to difficulties to fill out the pain survey)
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.